Subclinical rejection in tacrolimus-treated renal transplant recipients.
about
Role for urinary biomarkers in diagnosis of acute rejection in the transplanted kidneyAllograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profilingEvolution of endpoints for renal transplant outcome.Protocol biopsies after kidney transplantation.The significance of subclinical rejection and the value of protocol biopsies.Developing a tool for noninvasive monitoring of renal allografts.Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients.Urinary cell mRNA profiles predictive of human kidney allograft statusBorderline rejection after renal transplantation--to treat or not to treat.Surveillance biopsies in children post-kidney transplant.The value of long-term protocol biopsies after kidney transplantation.Advances in pharmacotherapy to treat kidney transplant rejection.Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants.Current status of pediatric renal transplant pathology.Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection: Where Do We Stand?Transplant trials with Tregs: perils and promises.Subclinical rejection in renal transplants is associated with low serum mannose-binding lectin levelsAcute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis.Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients.The short-term impact of protocol biopsies in a live-related renal transplant program using tacrolimus based immunosuppression.Use of mTOR inhibitors in human organ transplantation.Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction.The utility of 1- and 3-month protocol biopsies on renal allograft function: a randomized controlled study.Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus.Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study.Long-term results of protocol kidney biopsy directing steroid withdrawal in simultaneous pancreas-kidney transplant patients.Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study.Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
P2860
Q26771393-43C4F54D-397D-4CD8-B89D-8BEDFE293EBEQ26996813-2F1BD34F-56B1-497B-A819-31B25DA6BC0EQ35177426-7D08708B-2F09-4126-9B8B-5712ECEB2C8CQ36029862-BEB89C76-296F-448B-9BD2-B0F3CE64F054Q36517003-7F271339-8DD3-47BF-93FC-CA356029D868Q36641460-AD81E604-5EFA-4E72-8221-C3DF7922D14DQ37030707-16A677F7-8A92-4B4E-A77F-23D14628C26DQ37626743-D617E12B-2AD1-4DA1-95B2-508414E637F1Q37636475-F4C3127A-515A-4685-8F3A-B3DAFFC29FB5Q37906368-C42A1BDF-A8CA-4343-A1C6-1940B23371E6Q38212981-BAF0E011-8D1C-48FC-A984-B227C9FE4F5EQ38544529-38EC3A4F-FC5F-435F-AF2A-015B6F4B00F9Q38699017-47151D38-FD84-4C6D-AB41-BDCD0D39FA16Q38843499-A27C9428-C6EF-420C-B882-A6536EE9985EQ38893693-97D1E103-FF66-4B1B-A08A-4AD8347AEDAEQ39406891-F339DC0B-79C8-4148-B499-48BD41006B49Q41790517-E7BECFC8-F2A9-4704-B408-307979E01490Q41946081-0809D88B-30AB-4C27-8DF4-6937E6A1339BQ42378146-D0800F22-05E3-45E3-9E35-549537287AC5Q42552348-898439A7-1154-427B-8C42-D1010B27B78FQ43061556-CC5EAD83-5476-4108-9839-53344BD891D0Q46594085-84BB24E4-36BD-4772-A6DD-63B9623ED143Q46841454-C053A4C1-E44A-4D12-AF4A-29A624074069Q46936585-A9C99D45-1A70-4A37-9A8D-945D6BEE977CQ46972639-AF207526-80D4-4A8B-8B97-0961456A5456Q52683630-1D34FA26-D43F-4C1C-963A-0BF7289EAF64Q55515813-AC306537-8EF9-4426-9BF9-3A21C2D8E41DQ58733582-4AC57F36-8E90-464F-8777-106736AB2292
P2860
Subclinical rejection in tacrolimus-treated renal transplant recipients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Subclinical rejection in tacrolimus-treated renal transplant recipients.
@en
Subclinical rejection in tacrolimus-treated renal transplant recipients.
@nl
type
label
Subclinical rejection in tacrolimus-treated renal transplant recipients.
@en
Subclinical rejection in tacrolimus-treated renal transplant recipients.
@nl
prefLabel
Subclinical rejection in tacrolimus-treated renal transplant recipients.
@en
Subclinical rejection in tacrolimus-treated renal transplant recipients.
@nl
P2093
P1433
P1476
Subclinical rejection in tacrolimus-treated renal transplant recipients.
@en
P2093
Ari J Cohen
Donna J Lager
James M Gloor
Jorge A Velosa
Joseph P Grande
Mark D Stegall
Mary E Fidler
Matthew D Griffin
Mikel Prieto
Scott L Nyberg
P304
P356
10.1097/00007890-200206270-00023
P577
2002-06-01T00:00:00Z